米尔维克西安:专注于一种新的口服抗凝剂,该抗凝剂针对XIa因子进行血栓栓塞预防
Joseph Birchansky1, William H Frishman2
1From the Cayuga Medical Center, Ithaca, NY.
Cardiology in review
|February 2, 2024
概括
作为XIa因子抑制剂的Milvexian显示出预防血栓形成的潜力,降低了出血风险. 虽然一项试验错过了其主要的中风预防目标,但进一步的研究将评估其在各种心血管疾病中的有效性.
科学领域:
- 药理学 药理学是指药理学的学科.
- 心血管医学 心血管医学
- 血液学 血液学 血液学
背景情况:
- 对XI和XIa因子的抑制是针对抗凝固的研究.
- 向因子XIa可能会降低血栓形成的风险,而不会增加出血.
- 米尔维西安是一种正在研究中的小分子XIa因子抑制剂.
研究的目的:
- 评估milvexian在预防血栓形成方面的安全性和有效性.
- 评估milvexian在二次中风预防中的作用.
- 确定milvexian用于预防中风的剂量反应关系.
主要方法:
- 在健康参与者和肝/功能障碍者中进行的2期临床试验.
- 膝关节整形术后的VTE预防研究,比较milvexian与enoxaparin.
- 在患有缺血性中风或TIA的患者中进行二次中风预防试验.
主要成果:
- 在不同患者群体中,米尔维西安耐受性良好.
- 在使用milvexian后观察到的静脉瘤发病率和临床相关出血率较低.
- 二次性中风预防试验没有达到主要目标,但显示了症状性中风的风险降低.
结论:
- 米尔维西安显示出有利的安全性和预防VTE的潜力.
- 需要进一步的第三期试验来证实milvexian在预防中风和其他心血管事件中的有效性.
- 米尔维西安的开发继续用于二次中风预防,心房动和急性冠状动脉综合征.
更多相关视频
06:14Optimized LC-MS/MS Method for the High-throughput Analysis of Clinical Samples of Ivacaftor, Its Major Metabolites, and Lumacaftor in Biological Fluids of Cystic Fibrosis Patients
Published on: October 15, 2017
8.3K
05:53Intraluminal Drug Delivery to the Mouse Arteriovenous Fistula Endothelium
Published on: March 4, 2016
9.4K
相关概念视频
01:18Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
1.2K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.2K
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
698
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
698